Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26

Chemed Corporation (NYSE: CHE), a leading provider in end-of-life hospice care and plumbing services, has announced its upcoming financial results for the fourth quarter ending December 31, 2025. The earnings release is scheduled for February 25, 2026, shortly after the close of trading on the New York Stock Exchange. Following the earnings report, the company will conduct a conference call to discuss the quarterly results and provide insights on its business operations. This call is set for February 26, 2026, at 10 a.m. ET.

Participants interested in joining the call can access a live webcast through the Investor Relations section of Chemed’s official website or directly via the provided hosting link. Additionally, a teleconference registration option allows participants to obtain a personalized dial-in number after completing their registration. It is recommended that participants dial in 15 minutes prior to the start time to ensure they are connected.

For those unable to attend the live call, a taped replay will be made available roughly two hours post-conclusion. It can be accessed via the Chemed website as well.

Chemed Corporation operates under two principal subsidiaries: VITAS Healthcare, the largest hospice care provider in the U.S., and Roto-Rooter, the nation's premier plumbing and drain cleaning service. The company emphasizes that certain statements during the call may include forward-looking assertions concerning future events and performance. Investors are advised that these statements carry risks and uncertainties, and actual results may vary significantly. Chemed will not be obligated to update these forward-looking statements following unanticipated events or changes in expectations. For more information, Michael D. Witzeman can be contacted at (513) 762-6714.

As Chemed Corporation (NYSE: CHE) prepares to release its fourth-quarter earnings on February 25, 2026, investors should closely monitor key indicators and conference insights that could affect the company’s stock performance. The upcoming earnings report will provide detailed financial metrics for the final quarter of 2025, a pivotal period that could reveal trends influencing Chemed's subsidiaries—VITAS Healthcare and Roto-Rooter.

Analysts predict a focus on VITAS, the largest provider of hospice care in the U.S., as healthcare demand continues to rise amid an aging population. Investors should pay attention to metrics such as revenue growth, patient admission rates, and any commentary on reimbursement trends, which could significantly impact future profitability. Moreover, observations about regulatory challenges or changes in the healthcare landscape could affect investor sentiment.

On the other hand, Roto-Rooter, a leader in plumbing and drain cleaning, may experience seasonal fluctuations in demand, which are crucial in assessing quarterly performance. Key performance indicators, such as customer acquisition and service revenue, will be critical in understanding the segment's contribution to overall revenue.

During the February 26 conference call, listening for management’s forward-looking guidance is vital. Any updates on business strategies, technology investments, or expansion plans could sway investor confidence.

Investors should also be mindful of the valuations relative to the broader market, particularly in sectors like healthcare and essential services, which might see varied performance based on macroeconomic conditions. As Chemed is known for its steady growth and dividend reliability, maintaining a long-term perspective amid potential volatility could be beneficial. Overall, this earnings report and its subsequent insights could set the tone for Chemed’s short and medium-term stock trajectory, warranting close attention from investors.